GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Price-to-Owner-Earnings

AVCRF (Avricore Health) Price-to-Owner-Earnings : (As of May. 17, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health Price-to-Owner-Earnings?

As of today (2025-05-17), Avricore Health's share price is $0.03515. Avricore Health does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Avricore Health's Price-to-Owner-Earnings or its related term are showing as below:


AVCRF's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 26.26
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-17), Avricore Health's share price is $0.03515. Avricore Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00. Therefore, Avricore Health's PE Ratio (TTM) for today is 35.15.

As of today (2025-05-17), Avricore Health's share price is $0.03515. Avricore Health's EPS without NRI for the trailing twelve months (TTM) ended in was $0.00. Therefore, Avricore Health's PE Ratio without NRI for today is 35.15.

During the past 13 years, Avricore Health's highest PE Ratio without NRI was 100.00. The lowest was 13.33. And the median was 23.33.


Avricore Health Price-to-Owner-Earnings Historical Data

The historical data trend for Avricore Health's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Price-to-Owner-Earnings Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avricore Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avricore Health's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Avricore Health's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Avricore Health's Price-to-Owner-Earnings falls into.


;
;

Avricore Health Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Avricore Health's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.03515/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (OTCPK:AVCRF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Avricore Health Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Avricore Health's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.

Avricore Health Headlines

From GuruFocus

Avricore Grants Options

By GlobeNewswire GlobeNewswire 08-11-2022

VANC Announces Agreement for Acquisition of Corozon Platform

By GlobeNewswire GlobeNewswire 04-12-2018

Avricore Health Extends Closing of Placement

By GlobeNewswire GlobeNewswire 07-20-2019

Emerald Health Therapeutics Expands Strategic Investment in VANC

By Marketwired Marketwired 04-17-2018

Avricore Grants Options

By GlobeNewswire 08-31-2024

Avricore Health Announces Lifting of Management Cease Trade Order

By Marketwired Marketwired 06-04-2019

Avricore Health Amends Options

By GlobeNewswire GlobeNewswire 09-11-2020